idea 2,505 words
Contents

Mitophagy Gate Therapy: PINK1/Parkin + TFEB Priming

No AI portrait yet

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (61)

Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption
Score: 0.47
← Prevpg 4/4

Related Analyses (29)

Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived

Related Experiments (5)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Trehalose-induced lysosomal changes and TFEB activation
exploratory · proposed · Score: 0.90
Trehalose-induced lysosomal membrane permeabilization and TF
exploratory · proposed · Score: 0.90
Functional validation of trehalose effects on misfolded prot
exploratory · proposed · Score: 0.85
Exercise-BDNF-Mitophagy Biomarker Study in PD
clinical · proposed · Score: 0.40

See Also (4)

ABCD3 Gene
gene · KG edge: interacts_with
ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Memb
gene · KG edge: activates
ADORA2A Gene
gene · KG edge: targets
Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: activates

Knowledge Graph (8 edges)

PINK1-PRKN pathway mediates Mitophagy
MIRO1 dysregulation inhibits Mitophagy
pS65-Ub biomarker_for Mitophagy
Mitophagy associated_with Glucose Metabolism
PINK1/Parkin Pathway mediates Mitophagy
pS65-Ub involved_in Mitophagy
SCH79797 inhibits Mitophagy
DIZE upregulates Mitophagy

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.